Identification and characterization of novel mouse PDE4D isoforms: molecular cloning, subcellular distribution and

Ananth Chandrasekaran1, Kai Yee Toh, Sean Haoquan Low

  • 1Singapore Institute of Clinical Sciences, Singapore.

Cellular Signalling
|November 17, 2007
PubMed

Insights

Researchers identified novel short and supershort phosphodiesterase 4D (PDE4D) isoforms in mice. These variants, generated by alternative splicing, exhibit distinct subcellular localizations, potentially aiding selective inhibitor development.

Area of Science:

  • Molecular Biology
  • Enzymology

Background:

  • Phosphodiesterase 4D (PDE4D) is a key enzyme family with numerous splice variants.
  • PDE4 isoforms in humans, rats, and mice share significant homology in critical domains.

Purpose of the Study:

  • To clone and characterize short and supershort mouse PDE4D isoforms.
  • To investigate the role of unique N-terminal regions and transcription start sites in PDE4D isoform diversity.

Main Methods:

  • Cloning and characterization of novel PDE4D isoforms.
  • Analysis of 5' untranslated regions (5'UTRs) to identify transcription start sites.
  • Subcellular localization studies using deletion analysis.

Main Results:

  • Identification of novel mouse PDE4D isoforms: PDE4D2v3, PDE4D10, and orthologs of PDE4D1, PDE4D2v1, PDE4D2v2, PDE4D6.
  • Demonstration of diverse 5'UTR lengths, indicating multiple transcription start sites.
  • Short PDE4D1 isoforms localize to the nucleus, while supershort isoforms are cytoplasmic.
  • N-terminal regions are crucial for nuclear targeting and contain nuclear localization signals.

Conclusions:

  • Alternative mRNA splicing and multiple transcription start sites generate diverse PDE4D isoforms.
  • Unique N-terminal regions dictate subcellular localization (nucleus vs. cytoplasm).
  • Discovery of novel, tissue-specific PDE4D isoforms may facilitate the development of targeted phosphodiesterase inhibitors.

Related Concept Videos